These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 15008033)

  • 61. Improving oral pharmacologic treatment and management of type 2 diabetes.
    Dailey GE
    Manag Care; 2004 Feb; 13(2):41-7. PubMed ID: 15004930
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Adherence to oral therapy for type 2 diabetes: opportunities for enhancing glycemic control.
    Bartels D
    J Am Acad Nurse Pract; 2004 Jan; 16(1):8-16. PubMed ID: 15008033
    [TBL] [Abstract][Full Text] [Related]  

  • 63. How to select and combine oral agents for patients with type 2 diabetes mellitus.
    Chipkin SR
    Am J Med; 2005 May; 118 Suppl 5A():4S-13S. PubMed ID: 15850548
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The power of two: an update on fixed-dose combinations for type 2 diabetes.
    Harris SB
    Expert Rev Clin Pharmacol; 2016 Nov; 9(11):1453-1462. PubMed ID: 27498671
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Combination therapy with insulin and oral agents: optimizing glycemic control in patients with type 2 diabetes mellitus.
    Yki-Järvinen H
    Diabetes Metab Res Rev; 2002; 18 Suppl 3():S77-81. PubMed ID: 12324990
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Addition of insulin to oral therapy in patients with type 2 diabetes.
    Nelson SE; Palumbo PJ
    Am J Med Sci; 2006 May; 331(5):257-63. PubMed ID: 16702795
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Advancing therapy in type 2 diabetes mellitus with early, comprehensive progression from oral agents to insulin therapy.
    Vinik A
    Clin Ther; 2007; 29 Spec No():1236-53. PubMed ID: 18046925
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ; Bailey CJ
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Treatment of type 2 diabetes mellitus.
    Feinglos MN; Bethel MA
    Med Clin North Am; 1998 Jul; 82(4):757-90. PubMed ID: 9706120
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Type II diabetes mellitus.
    Edelman SV
    Adv Intern Med; 1998; 43():449-500. PubMed ID: 9506190
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Practical considerations and guidelines for dosing sulfonylureas as monotherapy or combination therapy.
    Bell DS
    Clin Ther; 2004 Nov; 26(11):1714-27. PubMed ID: 15639686
    [TBL] [Abstract][Full Text] [Related]  

  • 73.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.